Technological Processing of Dried Powdered Rosehips to Tablets Through Wet Granulation

The pseudo-fruits of Dog Rose are a rich source of L-ascorbic acid and several other active substances, which means their high supportive therapeutic potential. The study aimed to examine the impact of the chosen technological procedure for the preparation of tablets containing rosehip powder on the...

Full description

Saved in:
Bibliographic Details
Published inEUROPEAN PHARMACEUTICAL JOURNAL Vol. 70; no. 1; pp. 12 - 20
Main Authors Špaglová, M., Matušková, M., Lawson, M.K., Čuchorová, M., Čierna, M., Krchňák, D., Mikušová, V., Piešťanský, J., Mikuš, P.
Format Journal Article
LanguageEnglish
Published Sciendo 01.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The pseudo-fruits of Dog Rose are a rich source of L-ascorbic acid and several other active substances, which means their high supportive therapeutic potential. The study aimed to examine the impact of the chosen technological procedure for the preparation of tablets containing rosehip powder on the amount of L-ascorbic acid in the final pharmaceutical form. Drying of the plant drug was performed at room temperature to avoid possible thermal degradation of this heat-sensitive compound. Similarly, drying of the granules after wet granulation in the oven was replaced by natural drying at room temperature. The composition of two types of prepared granule formulations differed in the filler – lactose (LAC) or microcrystalline cellulose (MCC). Apart from the disintegration test, they meet the technological requirements for granules or tablets. Lactose was confirmed as a more suitable filler, which despite the unsuccessful disintegration of the granules, ensures the disintegration of tablets within 15 minutes even without the addition of a special excipient acting as a disintegrant. The content of L-ascorbic acid detected using isotachophoresis – capillary zone electrophoresis was 87.16 ± 5.06 µg in LAC tablets and 63.33 ± 2.83 µg in MCC tablets.
ISSN:2453-6725
2453-6725
DOI:10.2478/afpuc-2023-0061